• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Cardiology

Nonemergent percutaneous coronary intervention safe without on-site cardiac surgery services

bys25qthea
September 14, 2013
in Cardiology, Surgery
Reading Time: 3 mins read
Nonemergent percutaneous coronary intervention safe without on-site cardiac surgery services
Share on FacebookShare on Twitter

[tabs tab1=”2MM Rundown” tab2= “2MM Full Report”]

[tab]

Image: PD

1. Major adverse cardiac event rates at 30 days and 12 months after percutaneous coronary intervention are similar at hospitals with or without on-site cardiac surgery.

2. Procedural success rates are similar with or without on-site cardiac surgery while outcomes vary based on the hospitals.

Published today, this randomized study found that the safety and efficacy of PCI were noninferior at hospitals without on-site cardiac surgery. Previous studies have shown similar results. The results support more flexibility in choosing hospitals for patients seeking elective or non-emergent PCI. This is reassuring to patients in rural or medically underserved areas who may desire elective PCI but are concerned about the lack of cardiac surgery back-up at their local community hospitals.

RELATED REPORTS

The preoperative combination of evolocumab and rosuvastatin may not reduce major adverse cardiovascular events

The efficacy 3 months of dual antiplatelet therapy is similar to 12 months in patients with acute coronary syndrome

2 Minute Medicine Rewind December 29th, 2025

In addition, this study revealed that outcomes differed among hospitals. Presuming that randomization was adequate, this heterogeneity suggests that comprehensive reviews and outcome assurances may be necessary as we certify new PCI programs.

Click to read the study in NEJM

[/tab]

[tab]

Image: PD

1. Major adverse cardiac event rates at 30 days and 12 months after percutaneous coronary intervention are similar at hospitals with or without on-site cardiac surgery.

2. Procedural success rates are similar with or without on-site cardiac surgery while outcomes vary based on the hospitals.

This [randomized controlled] study assessed the impact of on-site cardiac surgery services on the safety and efficacy of PCI. Patients were randomized at a 3:1 ratio to undergo non-emergent PCI at hospitals without or with on-site cardiac surgery. Rates of MACE – defined as a composite of death, myocardial infarction, repeat revascularization, or stroke – were compared at 30 days and 12 months.

At 30 days, MACE occurred in 9.5% of patients assigned to sites without on-site cardiac surgery, compared to 9.4% with on-site cardiac surgery (p<0.001 for noninferiority). The MACE rates at 12 months were 17.3% vs 17.8% (p<0.001 for noninferiority).

Additionally, angiographic review showed no difference in procedural success rates between cohorts. Outcomes varied among hospitals, with median odds of 1.3 at 12 months– suggesting MACE may be 1.3 times as likely at one facility compared to another. The median odd was 1.5 at 30 days.

In sum: Published today, this randomized study found that the safety and efficacy of PCI were noninferior at hospitals without on-site cardiac surgery. Previous studies have shown similar results. The results support more flexibility in choosing hospitals for patients seeking elective or non-emergent PCI. This is reassuring to patients in rural or medically underserved areas who may desire elective PCI but are concerned about the lack of cardiac surgery back-up at their local community hospitals.

In addition, this study revealed that outcomes differed among hospitals. Presuming that randomization was adequate, this heterogeneity suggests that comprehensive reviews and outcome assurances may be necessary as we certify new PCI programs.

Click to read the study in NEJM

By Xiaozhou Liu and Marc Succi

More from this author: Omalizumab relieves symptoms in difficult-to-treat chronic idiopathic urticaria, New device reduces acid exposure in gastroesophageal reflux disease, Neurostimulation beneficial in Parkinson’s disease with early motor complications, Rivaroxaban has no net clinical benefit over enoxaparin for thromboprophylaxis in acutely ill patients, Long term functional outcomes similar with surgery, radiotherapy in prostate cancer patients

© 2013 2minutemedicine.com. All rights reserved. No works may be reproduced without written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT. Content is produced in accordance with fair use copyrights solely and strictly for the purpose of teaching, news and criticism. No benefit, monetary or otherwise, is realized by any participants or the owner of this domain.

[/tab]

[/tabs]

Tags: heart attackmyocardial infarctionPCIpercutaneous coronary intervention
Previous Post

Family presence during CPR associated with lower rates of emotional trauma

Next Post

Negative pressure wound therapy for open abdomens appears safe

RelatedReports

Using HEART score to risk stratify patients with chest pain is safe but underutilized in the ED
Cardiology

The preoperative combination of evolocumab and rosuvastatin may not reduce major adverse cardiovascular events

January 12, 2026
Using HEART score to risk stratify patients with chest pain is safe but underutilized in the ED
Cardiology

The efficacy 3 months of dual antiplatelet therapy is similar to 12 months in patients with acute coronary syndrome

January 12, 2026
Admission may not be needed following sleep apnea surgery
Weekly Rewinds

2 Minute Medicine Rewind December 29th, 2025

January 12, 2026
Lariat device for left atrial appendage exclusion associated with adverse events
Cardiology

Atrial fibrillation risk is high following coronary artery bypass grafting and is low but gradually accumulates following percutaneous coronary intervention

January 13, 2026
Next Post
Negative pressure wound therapy for open abdomens appears safe

Negative pressure wound therapy for open abdomens appears safe

Circulating tumor DNA used to monitor metastatic breast cancer

Circulating tumor DNA used to monitor metastatic breast cancer

Reminder intervention increases colorectal cancer screening rates

Overuse of colonoscopy widespread in the US

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

5-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Cataract surgery is associated with increased incidence of diabetic retinopathy among patients with diabetes
  • 2MM: AI Roundup: FDA clears autonomous blood draw robot, UHS acquires Talkspace, Databricks reaches $190 billion valuation, and AI-designed glioblastoma vaccine advances
  • Aletta brings autonomous robotics into routine blood collection
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.

2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

5-day free trial · cancel anytime

Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free · only $4.16/month

Start 5-day free trial

Then $49.90/year. Manage renewal in your account.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in